Corvus Pharmaceuticals
CRVS
CRVS
58 hedge funds and large institutions have $99.5M invested in Corvus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
58
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$911K | |
| 2 | +$880K | |
| 3 | +$480K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$341K |
| 5 |
Morgan Stanley
New York
|
+$92.8K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$956K | |
| 3 | -$787K | |
| 4 |
CI
Cowen Inc
New York
|
-$302K |
| 5 |
JPMorgan Chase & Co
New York
|
-$250K |